US government purchases drug used in radiological and nuclear emergencies

As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).

ARS, also known as radiation sickness, occurs when a person’s entire body is exposed to a high dose of penetrating radiation, reaching internal organs in a matter of seconds. Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.

aspr.hhs HHS purchases drug for use in radiological and nuclear emergencies

Hmmm, are they expecting some kind of radiation emergency perhaps? Like a global nuclear war maybe?

One thought on “US government purchases drug used in radiological and nuclear emergencies

  1. “Symptoms of ARS injuries include impaired blood clotting as a result of low platelet counts, which can lead to uncontrolled and life-threatening bleeding.” Hm, maybe the clotshot is a proactive treatment.

    Liked by 1 person

Comments are closed.